nk510
Showing 1 - 3 of 3
Osteosarcoma, Soft Tissue Sarcoma Trial in Shanghai (NK510)
Recruiting
- Osteosarcoma
- Soft Tissue Sarcoma
- NK510
-
Shanghai, ChinaShanghai General Hospital
Oct 31, 2023
Gastric Cancer Trial in Shanghai (NK510, Tislelizumab,atezolizumab or Trastuzumab)
Enrolling by invitation
- Gastric Cancer
- NK510
- Tislelizumab,atezolizumab or Trastuzumab
-
Shanghai, ChinaShanghai Tenth People's Hospital
Oct 22, 2023
NSCLC Trial in Nanjing (NK510, Tislelizumab,atezolizumab or sugemalimab)
Recruiting
- NSCLC
- NK510
- Tislelizumab,atezolizumab or sugemalimab
-
Nanjing, Jiangsu, ChinaGeneral Hospital of Eastern Theater Command
Oct 23, 2023